当前位置: X-MOL 学术J. Clin. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2021 , DOI: 10.1172/jci152740
Cristina Avendaño-Solá 1 , Antonio Ramos-Martínez 2 , Elena Muñez-Rubio 2 , Belen Ruiz-Antorán 1 , Rosa Malo de Molina 3 , Ferran Torres 4, 5 , Ana Fernández-Cruz 2 , Jorge Calderón-Parra 2 , Concepcion Payares-Herrera 1 , Alberto Díaz de Santiago 2 , Irene Romera-Martínez 6 , Ilduara Pintos 2 , Jaime Lora-Tamayo 7 , Mikel Mancheño-Losa 7 , Maria L Paciello 8 , A L Martínez-González 9 , Julia Vidán-Estévez 10 , Maria J Nuñez-Orantos 2 , Maria Isabel Saez-Serrano 11 , Maria L Porras-Leal 12 , Maria C Jarilla-Fernández 13 , Paula Villares 14 , Jaime Pérez de Oteyza 15 , Ascension Ramos-Garrido 16 , Lydia Blanco 17 , Maria E Madrigal-Sánchez 18 , Martin Rubio-Batllés 19 , Ana Velasco-Iglesias 20 , José R Paño-Pardo 21 , J A Moreno-Chulilla 22 , Eduardo Muñiz-Díaz 23 , Inmaculada Casas-Flecha 24 , Mayte Pérez-Olmeda 25 , Javier García-Pérez 26 , Jose Alcamí 26 , Jose L Bueno 6 , Rafael F Duarte 6 ,
Affiliation  

BACKGROUND. Passive immunotherapy with convalescent plasma (CP) is a potential treatment for COVID-19. Evidence from controlled clinical trials is inconclusive.

中文翻译:

一项针对 COVID-19 肺炎住院患者恢复期血浆的多中心随机开放标签临床试验

背景。使用恢复期血浆 (CP) 的被动免疫疗法是 COVID-19 的一种潜在治疗方法。来自对照临床试验的证据尚无定论。
更新日期:2021-10-17
down
wechat
bug